Treatment for Binge Eating Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Binge Eating Disorder+1 More
Eligibility
18 - 50
All Sexes
What conditions do you have?
Select

Study Summary

This trial will comprehensively characterize circadian system dysfunction in BED, and evaluate it as a potential therapeutic target.

Eligible Conditions
  • Binge Eating Disorder
  • Circadian Rhythm Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Naltrexone
1
Naltrexone and Bupropion
1
Psychotherapy

Study Objectives

2 Primary · 7 Secondary · Reporting Duration: Phase 2 baseline (visit 0) to endpoint, on average one month.

Phase 1 baseline (visit 0)
Phase 1 Association between DLMO and binge eating days/week
Phase 1 Dim Light Melatonin Onset (DLMO)
Phase 1 Locomotor activity acrophase
Phase 1 MEQ
Phase 1 Midline Estimating Statistic of Rhythm (MESOR)
Phase 2 baseline (visit 0) to endpoint, on average one month.
Phase 2 Binge eating days/week
Phase 2 Dim Light Melatonin Onset (DLMO)
Phase 2 Locomotor activity acrophase
Phase 2 baseline (visit 0) to endpoint

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Naltrexone
2
Naltrexone and Bupropion
2
Psychotherapy

Trial Design

0 Treatment Group

80 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · Has Placebo Group · Phase 1 & 2

Trial Logistics

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: phase 2 baseline (visit 0) to endpoint, on average one month.

Who is running the clinical trial?

University of CincinnatiLead Sponsor
388 Previous Clinical Trials
635,559 Total Patients Enrolled
Lindner Center of HOPEOTHER
28 Previous Clinical Trials
1,315 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,555 Previous Clinical Trials
1,822,305 Total Patients Enrolled
Francisco Romo-Nava, MD, PhDPrincipal Investigator - University of Cincinnati/ Lindner Center of HOPE
University of Cincinnati

Eligibility Criteria

Age 18 - 50 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are receiving psychotherapy and agree to continue during the study.
You are using an effective contraceptive method.
You have a history of other psychiatric disorders that are not severe.
You are between the ages of 18 and 50 years, inclusive.
You have BED by DSM-5 criteria confirmed by SCID-5.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top